Dermsquared

AI-powered search

On-Demand CME Videos

FC24: Practical Insights and Pitfalls for Psoriatic Disease in Skin of Color: Early Diagnosis for Effective Treatment: An Online Activity

About

Practical Insights and Pitfalls for Psoriatic Disease in Skin of Color: Early Diagnosis for Effective Treatment: An Online Activity

This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Availability

In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

December 12, 2024

Expiration Date:

December 12, 2025

Learning Objectives

At the completion of this activity, participants should be better able to:

List the barriers of early diagnosis of psoriasis in skin of color and how to overcome them
Describe strategies for multidisciplinary collaboration to more promptly diagnose psoriatic disease in patients with skin of color
Review the role of systemic therapies for the management of psoriatic disease in skin of color patients

Intended Audience

This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

Faculty

Tina Bhutani, MD, MAS

CEO, Synergy Dermatology
Associate Clinical Professor of Dermatology
University of California, SF
San Francisco, CA

Tiffany Mayo, MD

Associate Professor

The University of Alabama at Birmingham

Dermatology Vice Chair of Diversity, Equity and Inclusion

Department Director of Clinical Trials

Birmingham, Alabama

Mona Shahriari, MD

Dermatologist, Yale University School of Medicine
Central CT Dermatology
Cromwell, CT

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

Disclosures are as follows:

Tina Bhutani, MD, MAS

Advisory Board: Abbvie, Arcutis, Aslan, Boehringer-Ingelheim, Bristol Myers Squibb, Dermavant, Galderma, Incyte, Janssen, Leo, Lilly, Pfizer, Novartis, Sanofi, SUN Pharma, Takeda, and UCB

Grant/Research Support: Amgen, Castle, CorEvitas, Novartis, Pfizer, and Regeneron

Speakers’ Bureau Honoraria: Amgen, Arcutis, Galderma, Janssen, Lilly and Leo

Ownership Interest (privately held): Owner of Synergy Dermatology

Tiffany Mayo, MD

Advisory Board: Abbvie, Arcutis, BMS, Bodewell, Janssen, Lilly, Leo Novartis, Pfizer, UCB

Grant/Research Support: Acelyrin, BMS, ChemoCentryx, Galderma, Janssen, Lilly, Pfizer

Mona Shahriari, MD

Grant/Research Support: AbbVie, Dermira, Cara, Dermavant, Novartis, Union

Consultant: Abbvie, BMS, Dermavant, Leo, Lilly, Sanofi, Regeneron, UCB

Speakers’ Bureau or Honoraria: Abbvie, BMS, Lilly, Leo, Janssen, Dermavant

The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.